PDX INSIGHTS
PIONEERING CANCER RESEARCH
Model Details

Patient Information for Model: TCH-AML005a

Model Contact
Model: TCH-AML005a
Model Contact: Michele Redell
Institution: TCH Leukemia PDX Program
Email: mlredell@texaschildrens.org

Patient Information
Clinical Timeline


Clinical Information at Collection
Clinical Biomarkers/Mutations

Model Information for Model: TCH-AML005a

Model Details - Initial Implantation of Patient Tissue
Mutations (Cancer Gene Census List)
Mutation data is currently not available.

CNV
There are no omics data for this model.


Histology Information for Model: TCH-AML005a
There are no histology images for this model.













Metastasis Information for Model: TCH-AML005a
 
Patient
PDX
Central Nervous System
Face
Gingiva
Liver
Lymph node
Orbital chloroma
Retinas
Skin
Spleen
Testis
Tongue

Patient Treatment Information for Model: TCH-AML005a

Event IdTreatmentTreatment SettingAge at StartAge at EndDurationClinical ResponseMeasurable Residual Disease
10ADE10De Novo16.71Unknown97%
20Azacitidine/Flud/CytarabineRefractory16.791UnknownInduction Failure 10%
30Azacitidine/Flud/CytarabineRemission16.911UnknownRemission0%
40Stem Cell TransplantRemission17.071UnknownRelapse6.5%
60azacitidine/venetoclaxRelapse17.471UnknownRefractory
70Vorino/Decitabine/FLAGRefractory17.961UnknownRefractory













Please wait...

SITE LINKS
Collections
Omics Tools
Publications
Our Team
Contact Us

COLLECTIONS
BladderBreastLeukemiaLiverPancreasSarcoma
CONTACT
PDX Development Unit
BCM PDX Core
PDX Pediatric Liver Program
Baylor College of Medicine
SUPPORTED BY
Cancer Prevention and Research
Institute of Texas (RP220646)
Dan L Duncan Cancer Center (P30 Cancer Center Support Grant NCI-CA125123)
Advanced Technology Core

© 2024 Biomedical Informatics Group, Dan L Duncan Comprehensive Cancer Center, Baylor College of Medicine